From Bioscience to Biobusiness Success
Dr. Robert Bowser was recruited to the Barrow Neurological Institute and St. Joseph’s Hospital & Medical Center to direct an ALS research center using philanthropic support from Mr. Ira Fulton. He arrived to the Phoenix area in August of last year after 18 years on the faculty at the University of Pittsburgh School of Medicine. Dr. Bowser’s research focuses on biomarkers of neurologic disease and he will describe how success in his academic research has also led to success in the world of biotechnology.
Senestech: Humane Pest Control
Senestech is a platform biotechnology company specializing in reproductive physiology. Our mission: Senestech aims to provide for the more humane treatment of animals, to improve the quality of human life, and to enhance environmental stewardship through global application of our animal fertility control technology. We are currently applying our revolutionary technology to the control of rats and mice in both agricultural and urban settings.
Yulex moves into the AZBio Fast Lane
http://www.yulex.com/ Rubber and commerce go hand in hand and rubber products are everywhere. Yulex Corporation is the global leader in guayule-based biomaterials for a wide range of markets and diverse applications. Yulex’s Guayule BioRubber Emulsions and BioRubber Solids have medical, consumer, and industrial applications to grow an increasingly diverse market community with ultra-pure, high-performance products. From medical devices to fabric coatings, and from bedding to industrial packaging adhesives, Yulex also provides technical and product development guidance and support, and even custom material compounding and formulation. Yulex Corporation, a technology, marketing and biomaterial product development company that applies sustainable crop science, clean bioprocessing, and materials science for the production of natural, allergy-friendly BioRubber derived from the renewable, crop Guayule was honored with the 2013 AZBio Fast Lane Award from the Arizona Bioindustry Association
2012 AZBio Fast Lane Award Winner - Ulthera
Beauty and Growth – Ulthera, Inc Ulthera’s mission is to work with physicians to provide therapeutic ultrasound to improve the appearance and health of patients worldwide. The company is not only defined by its proprietary technology, but also its people. Ulthera’s team consists of experts in their respective fields who are aligned by the strength of the company’s mission and its leadership. Ulthera was founded in 2004 to leverage seven years of prior scientific research in therapeutic ultrasound for aesthetic and medical applications. In 2009, the Ulthera® System received FDA approval in the United States and is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy® – the procedure enabled by the System – is a non-invasive treatment of the face to achieve a brow lift. Ulthera’s robust scientific foundation and relentless pursuit of superior clinical outcomes have resulted in the rapid global uptake of the Ulthera platform. As Ulthera continues to develop and provide more applications for its platform, the company also remains committed to bringing value to physicians and their patients. In 2006, Matt Likens was hired as President and CEO of Ulthera by founder and owner Michael Slayton, Ph. D, with the expectation of obtaining FDA approval for Ulthera’s product and service (known as Ultherapy) within three months. Less than two years into his tenure at Ulthera, Matt found himself navigating this venture capital backed start-up though the worst economic downtown since the Great Depression. The Company also found itself facing an increasing skeptical and less commercially friendly US Food and Drug Administration (FDA) regime. With both of these risks significantly threatening the Company’s viability, Matt decided to change the Company’s regulatory pathway and focus by obtaining CE Mark from the European Union prior to obtaining FDA clearance. If this bet paid off, Ulthera’s regulatory runway would be significantly reduced and the Company would be able to generate sales in the European market. These revenues would also allow the Company to lessen the need to obtain additional venture capital financing thus reducing additional dilution to the Company’s current shareholders. While risky, the core of this decision was based on the multinational experience Likens attained at Baxter and his general entrepreneurial nature. The bet ultimately paid off. Today, Ulthera is a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. More than 1,000 Ulthera Systems have been sold globally while treatments performed using the System have surpassed 100,000.
Washington Update from Congressman Paul Gosar DDS
Congressman Paul Gosar (AZ-4th District) is a health care provider and small business owner who is focused on bringing jobs back to the district, reforming health care, reining in government spending and ensuring that his constituents are involved in the solution process. Congressman Paul Gosar serves on the House Committee on Oversight and Government Reform including as t he Vice Chairman of the House Subcommittee on Energy Policy, Health Care, and Entitlements which has oversight over federal health care policy, food and drug safety, energy policy, solvency of federal entitlement programs. He also serves on the Subcommittee on Economic Growth, Job Creation, and Regulatory Affairs which has oversight jurisdiction regulatory affairs, impediments to economic growth and job creation, monetary policy, banking, infrastructure, and tax policy as well as the Subcommittee on National Security which has Oversight jurisdiction over national security, homeland security, foreign operations, immigration, emergency management, and criminal justice.
Company Presentation: Invoy Technologies, LLC
Exhaled Breath: A Portal for Pain-Free Biochemical Analysis Invoy is engaged in the development and commercialization of breath analysis devices for a broad range of applications. Invoy plans to offer patients the ability to monitor their health in the convenience of their own home – with a prescription-based breath analysis device called the Voyager. The process is pain-free and the results are quick and accurate; giving patients peace of mind and confidence in using this new-to-the-market device.
UA College of Medicine Phoenix | 2013 Commencement
2013 Commencement UA College of Medicine – Phoenix Fifty University of Arizona College of Medicine -- Phoenix medical students were officially conferred with their medical degrees at ceremonies on May 8 in the third graduation for the downtown Phoenix medical school. Read more: http://phoenixmed.arizona.edu